← SynDRA
ROBALZOTAN
SynDRA canonical compound SYN0025804 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | HTR1A |
| Mechanism of action | serotonin receptor antagonist |
All known targets
Mechanisms of action (all sources)
- HTR1A ANTAGONIST
- Serotonin 1a (5-HT1a) receptor antagonist
- serotonin receptor antagonist
Cross-references
Synonyms
- Azd-7371
- Azd7371
- NAD-299
- UNII-I18M56OGME
- I18M56OGME
- AZD-7371
- (R)-3-(Dicyclobutylamino)-8-fluoro-5-chromancarboxamide
- (R)-3-(Dicyclobutylamino)-8-fluorochroman-5-carboxamide
- Robalzotan [INN]
- Robalzotan [INN:BAN]
- (3R)-3-[di(cyclobutyl)amino]-8-fluoro-3,4-dihydro-2H-chromene-5-carboxamide
- AC1MHOZC
- GTPL72
- SCHEMBL115079
- NAD299
- CHEMBL1628569
- DTXSID30168743
- ZINC3811952
- AKOS022180489
- VC30713
- NCGC00370859-01
- AJ-45676
- LS-182403
- (R)-3-(dicyclobutylamino)-8-fluorochromane-5-carboxamide
- NAD 299
- (3R)-3-(di(cyclobutyl)amino)-8-fluorochroman-5-carboxamide
- robalzotanum
- RefChem:179719
- DTXCID9091234
- AZD7371
- orb1702869
- GLXC-04840
- HY-10351
- NS00069258
- T24721
- (R)-3-(Dicyclobutylamino)-8-fluoro-5-chromancarboxamide.
- robalzotan tartrate hydrate
- Робалзотан
- ロバルゾタン
Look up ROBALZOTAN in the interactive SynDRA portal →